Clinical Trial Update: Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation [Phase 1, Phase 2]

View source ↗

Summary

Interventional study investigating implantation of human embryonic stem cell–derived retinal pigment epithelium (RPE) for retinitis pigmentosa due to monogenic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• hESC-derived RPE

Snippet

Sponsor: Centre d'Etude des Cellules Souches | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING